# UNC Chapel Hill x SAS Antiviral Drug Development Partnership: partnership

Canonical ID: `aa6467ea-b81c-40c1-a4d8-bbdf5938f31b`

SAS and UNC Chapel Hill partnered to accelerate antiviral drug discovery through the Rapidly Emerging Antiviral Drug Development Initiative. SAS contributes AI and machine learning capabilities to advance drug discovery for future pandemic preparedness.

- **Type:** development
- **Status:** active
- **Verification posture:** verified

## Parties (2)

- [University of North Carolina at Chapel Hill](https://registry.deploy.report/companies/university-of-north-carolina-at-chapel-hill.md) co developer
- SAS Institute _(off-registry)_ technology provider

## Sources (1)

1. https://uncnews.unc.edu/2021/09/14/sas-and-unc-chapel-hill-partner-to-accelerate-antiviral-drug-development/


_API: GET /v1/partnerships/unc-chapel-hill-x-sas-antiviral-drug-development-partnership · canonical URL: /partnerships/unc-chapel-hill-x-sas-antiviral-drug-development-partnership_